Business ❯ Biotechnology

Biopharmaceuticals

Manufacturing AI in Healthcare Research and Development Muscle Activators Antibody Drugs Acquisitions mRNA Technology Cancer Research Leadership Metabolic Diseases Corporate Affairs Corporate Culture Contract Development and Manufacturing Biosimilars Oncology Regulatory Affairs Plasma-Derived Products

Samsung Biologics Launches SFr1.46 Billion Cash Bid for PolyPeptide

The purchase aims to add peptide manufacturing to Samsung's CDMO business to accelerate entry into GLP‑1 therapeutics.

Securities Suit Filed Against ADMA Biologics as Law Firms Seek Lead Plaintiffs

KALA BIO Says First AI Agent Ships in Two Weeks as Shares Soar Pre-Market

FDA Rejects Disc Medicine’s Bitopertin for EPP After Questioning Surrogate Endpoint

Propanc Biopharma Lines Up Up to $100 Million From Hexstone to Launch Digital-Asset Treasury and Speed PRP Toward Trials

Cytokinetics Investors Urged to Seek Counsel Before Nov. 17 Lead-Plaintiff Deadline in Aficamten Case